Stock listing
NASDAQ:BIVV Bioverativ Inc Stock
Follow Bioverativ Inc into a list and get an email when it puts out news.
Last close · NASDAQ:BIVV
$104.98 USD
Close on Mar 8, 2018 · No longer trades
- Lowest – highest close
- $42.40 – $104.98 USDSince Feb 2, 2017 · lowest Feb 9, 2017 · highest Mar 8, 2018
Delisted NASDAQ:BIVV no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:BIVV
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Bioverativ Inc on 6ix
- Decks
- 1 deck · latest Jan 6, 2017
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Day (January 2017) | Investor day | 50 slides | Jan 6, 2017 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Alexander J Denner Other companies: Ironwood Pharmaceuticals, Inc. (Director · Since at least Nov 9, 2020); The Medicines Company (Director · Feb 2, 2016 – Jan 6, 2020 · Past); Ariad Pharmaceuticals Inc (Director · Feb 20, 2014 – Feb 16, 2017 · Past); VIVUS Inc (Director · Aug 14, 2013 – Oct 30, 2015 · Past); Biogen Inc. (Director · Jun 10, 2009 – Jun 15, 2022 · Past); Amylin Pharmaceuticals LLC (Director · Jun 9, 2009 – Aug 8, 2012 · Past); Viskase Holdings, Inc. (Director · May 21, 2009 – Jan 2, 2013 · Past); Savara, Inc. (Director · Oct 26, 2006 – Oct 16, 2009 · Past) | Director · Jan 10, 2017 – Mar 8, 2018 · Past |
| Brian S. Posner Other companies: Dyne Therapeutics, Inc. (Board Member · Since at least Oct 1, 2025); BG Medicine Inc (Director · Since at least Feb 13, 2012); Arch Capital Group Ltd. (Director · Since at least Nov 4, 2010); Anadys Pharmaceuticals Inc (Director · Aug 22, 2011 – Aug 22, 2011 · Past); Biogen Inc. (Director · Jul 23, 2008 – Dec 31, 2022 · Past); LMP Capital and Income Fund Inc (Officer of the Adviser · Oct 11, 2006 – Oct 11, 2006 · Past) | Director · Jan 10, 2017 – Mar 8, 2018 · Past |
| Coelho Rogerio Vivaldi Other companies: Viatris Inc. (Director · Since at least Jun 3, 2024); Crinetics Pharmaceuticals, Inc. (Director · Since at least Jan 3, 2022); Sigilon Therapeutics Inc (PRESIDENT AND CEO, Director · Dec 3, 2020 – Aug 11, 2023 · Past); Spark Therapeutics Inc (Chief Commercial Officer · Jan 29, 2015 – Jul 15, 2016 · Past); Minerva Neurosciences, Inc (President and CEO, Director · Jun 30, 2014 – Jun 30, 2014 · Past) | EVP, Chief Global Therapeutics · Dec 22, 2016 – Mar 8, 2018 · Past |
| Geno Germano Other companies: Harmony Biosciences Holdings, Inc. (Director · Since at least Apr 2, 2026); Entera Bio Ltd. (Chairman of the Board · Since at least Feb 4, 2026); Precision BioSciences, Inc. (Director · Since at least Mar 10, 2020); Sage Therapeutics Inc (Director · Since at least Jun 6, 2018); The Medicines Company (Director · Nov 9, 2017 – Jan 6, 2020 · Past) | Director · Jan 31, 2018 – Mar 8, 2018 · Past |
| Richard Brudnick Other companies: InflaRx N.V. (Board Member · Since at least Mar 18, 2026); Scholar Rock Holding Corporation (Director · Since at least Apr 6, 2023); Prime Medicine, Inc. (Chief Business Officer · Oct 19, 2022 – May 20, 2025 · Past); VolitionRx Limited (Director · Mar 25, 2021 – Jan 12, 2023 · Past); Codiak BioSciences Inc (See Remarks · Oct 13, 2020 – Feb 16, 2022 · Past) | EVP, Business Development · Dec 22, 2016 – Mar 8, 2018 · Past |
| Anna Protopapas Other companies: Nuvalent, Inc. (Director · Since at least Mar 30, 2022); Mersana Therapeutics Inc (Director · Since at least Jun 27, 2017); Dicerna Pharmaceuticals Inc (Director · Jan 23, 2019 – Jun 3, 2021 · Past); Ariad Pharmaceuticals Inc (Director · Feb 1, 2016 – Feb 16, 2017 · Past) | Director · Feb 28, 2017 – Mar 8, 2018 · Past |
| John Cox Other companies: Dyne Therapeutics, Inc. (President and Chief Executive Officer · Since at least Mar 25, 2024); Sigilon Therapeutics Inc (Director · Dec 3, 2020 – Aug 11, 2023 · Past); Repligen Corporation (Director · Nov 15, 2013 – Mar 24, 2020 · Past); Biogen Inc. (EVP Pharmaceutical Oper & Tech · Nov 1, 2011 – Apr 1, 2016 · Past) | Chief Executive Officer, Director · Dec 22, 2016 – Mar 8, 2018 · Past |
| John Greene Other companies: Northrop Grumman Corporation (Corporate Vice President and Chief Financial Officer · Since at least Jan 7, 2026); CRISPR Therapeutics AG (Director · Since at least Jun 11, 2019); Discover Financial Services (EVP, Chief Financial Officer · Sep 18, 2019 – May 18, 2025 · Past); Willis Towers Watson Public Limited Company (Chief Financial Officer · Jun 2, 2014 – Nov 9, 2015 · Past) | EVP, CFO and Treasurer · Dec 22, 2016 – Mar 8, 2018 · Past |
| Louis J Paglia Other companies: Sarissa Capital Acquisition Corp (Director · Oct 20, 2020 – Oct 23, 2020 · Past); Arch Capital Group Ltd. (Director · Jul 14, 2014 – May 4, 2023 · Past); Northstar Asset Management Group Inc (Director · Jun 26, 2014 – Dec 30, 2016 · Past); NorthStar Realty Finance Corp (Director · Mar 1, 2006 – Jan 10, 2017 · Past) | Director · Jan 10, 2017 – Mar 8, 2018 · Past |
| Lucia Celona Other companies: Dyne Therapeutics, Inc. (Chief Human Resources Officer · Since at least Nov 5, 2026); Apellis Pharmaceuticals, Inc. (See Remarks · Aug 5, 2019 – Feb 10, 2020 · Past) | EVP, HR & Corp Commun. Officer · Dec 22, 2016 – Mar 8, 2018 · Past |
All 12 people
| Person | Seat |
|---|---|
| Timothy Harris Other companies: BG Medicine Inc (Director · Since at least Feb 3, 2011); CapForce Inc. (Director · May 4, 2015 – Jun 13, 2018 · Past) | EVP, R & D · Apr 10, 2017 – Mar 8, 2018 · Past |
| Andrea DiFabio Other companies: Xenon Pharmaceuticals Inc. (Chief Legal Officer and Corporate Secretary · Since at least Nov 7, 2022) | EVP, Chief Legal Officer · Dec 22, 2016 – Mar 8, 2018 · Past |
Log in to ask 6ix AI your own questions about Bioverativ Inc.